03:29 AM EST, 01/21/2026 (MT Newswires) -- Joshua B Cohen, Director, Co-Chief Executive Officer, on January 15, 2026, sold 138,167 shares in Amylyx Pharmaceuticals ( AMLX ) for $1,878,094. Following the Form 4 filing with the SEC, Cohen has control over a total of 3,379,465 common shares of the company, with 3,379,465 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1658551/000119312526017057/xslF345X05/ownership.xml